Based on GEP, a 3-gene model (TNFRSF8, BATF3, and TMOD1) was developed to separate ALK– ALCL from PTCL-NOS, with 97% accuracy (61). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.